Charles Schwab Investment Management Inc. Has $164.06 Million Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Charles Schwab Investment Management Inc. lifted its position in Corteva, Inc. (NYSE:CTVAGet Rating) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,469,865 shares of the company’s stock after buying an additional 80,370 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Corteva were worth $164,056,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Sierra Capital LLC lifted its stake in shares of Corteva by 402.9% in the fourth quarter. Sierra Capital LLC now owns 523 shares of the company’s stock worth $25,000 after buying an additional 419 shares during the last quarter. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Corteva in the fourth quarter worth $25,000. Elmwood Wealth Management Inc. acquired a new stake in shares of Corteva in the fourth quarter worth $26,000. Paragon Capital Management Ltd acquired a new stake in shares of Corteva in the fourth quarter worth $37,000. Finally, First Personal Financial Services lifted its stake in shares of Corteva by 166.0% in the fourth quarter. First Personal Financial Services now owns 798 shares of the company’s stock worth $38,000 after buying an additional 498 shares during the last quarter. Institutional investors and hedge funds own 79.46% of the company’s stock.

Shares of Corteva stock opened at $59.23 on Friday. The stock has a market capitalization of $42.86 billion, a price-to-earnings ratio of 25.20, a P/E/G ratio of 1.74 and a beta of 0.65. The firm’s 50-day moving average price is $57.76 and its two-hundred day moving average price is $51.68. The company has a current ratio of 1.64, a quick ratio of 1.13 and a debt-to-equity ratio of 0.04. Corteva, Inc. has a 1-year low of $40.60 and a 1-year high of $62.04.

Corteva (NYSE:CTVAGet Rating) last posted its earnings results on Wednesday, May 4th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.16. Corteva had a net margin of 10.72% and a return on equity of 6.70%. The company had revenue of $4.60 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the previous year, the company posted $0.79 earnings per share. Corteva’s quarterly revenue was up 9.5% compared to the same quarter last year. As a group, equities research analysts predict that Corteva, Inc. will post 2.53 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 15th. Stockholders of record on Friday, May 13th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend is Thursday, May 12th. Corteva’s dividend payout ratio (DPR) is currently 23.83%.

A number of equities analysts recently issued reports on the stock. Redburn Partners raised shares of Corteva from a “neutral” rating to a “buy” rating in a research report on Monday, January 31st. Citigroup boosted their target price on shares of Corteva from $59.00 to $66.00 and gave the stock a “buy” rating in a research report on Tuesday, March 22nd. Vertical Research lowered shares of Corteva from a “buy” rating to a “hold” rating and set a $58.00 target price on the stock. in a research report on Thursday, April 14th. JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and set a $58.00 target price on the stock. in a research report on Friday, May 6th. They noted that the move was a valuation call. Finally, KeyCorp boosted their target price on shares of Corteva from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 5th. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $59.54.

In other news, Director Klaus A. Engel sold 3,000 shares of Corteva stock in a transaction that occurred on Tuesday, March 15th. The shares were sold at an average price of $52.76, for a total value of $158,280.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.08% of the company’s stock.

Corteva Profile (Get Rating)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAGet Rating).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.